The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial ...
We recently published a list of 10 Best Australian Stocks to Buy According to Billionaires. In this article, we are going to ...
Trading in shares of Opthea is halted in the U.S. and Australia ahead of planned update by the clinical-stage biopharmaceutical company on a late-stage study of its lead product candidate ...
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
4d
Stockhead on MSNHealth Check: These biotechs are awaiting key announcements on St Patrick’s DayOn St Patrick's Day, investors hope for the luck of the Irish ahead of Opthea's key trial update and Imricor's ambitious fund ...
Opthea Limited’s OPT share price has dipped by 11.56%, which has investors questioning if this is right time to buy.
2d
TipRanks on MSNOpthea Limited Suspends Trading Pending Clinical Trial ResultsOpthea Limited ( ($AU:OPT) ) has shared an update. Opthea Limited has requested a voluntary suspension of its securities from trading on the ASX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results